Skip to main content

News

February 03, 2020
Merit Medical Systems, Inc. announces that both its EmboCube (syringe-loaded embolization gelatin foam) and Torpedo (uniform, pre-shaped gelatin foam loaded into a cartridge with optional blunt stylet) devices are now FDA indicated for the…
January 08, 2020

) WAYNE, Pa. — Cagent Vascular, a developer of serration technology for vessel dilatation in cardiovascular disease interventions, announces the initiation of the PRELUDE-BTK…

December 19, 2019
An analysis of data from the ATTRACT trial published in the online version of the January Journal of Vascular Surgery: Venous and Lymphatic Disorders (JVSVL) reveals that quality of life (QOL) measures improve after pharmacomechanical catheter-…
November 22, 2019
erit Medical Systems, Inc.,  a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy, announced…
November 22, 2019

CASTLE PINES, Colo., Nov.

November 21, 2019
Medtronic plc today announced U.S. Food and Drug Administration (FDA) approval of the IN.PACT™ AV drug-coated balloon (DCB), a paclitaxel-coated balloon indicated for the treatment of failing arteriovenous (AV) access in patients with end-stage…
November 08, 2019
Shockwave Medical, Inc., a pioneer in the development of Intravascular Lithotripsy (IVL) to treat complex calcified cardiovascular disease, today announced commercial availability of the Shockwave S4 Peripheral IVL Catheter in select approved…
November 06, 2019
Boston Scientific announced positive data for two devices within the peripheral drug-eluting product portfolio during separate late-breaking clinical trial presentations at Vascular InterVentional Advances (VIVA) meeting in Las Vegas.
November 06, 2019
LimFlow SA, a pioneer in the development of minimally-invasive technology for the treatment of chronic limb-threatening ischemia (CLTI), a severe form of peripheral artery disease (PAD), today announced the presentation of positive six-month data…
November 06, 2019
Two-year data from the First-in-Human study of SELUTION SLR™, MedAlliance’s novel sirolimus-eluting balloon, was presented today at VIVA 2019 by Principal Investigator Professor Thomas Zeller
Back to Top